"With the expertise and template laid down by the work we have done for patients with the innovative drugSCENESSE®, we expect the new molecules to go through the regulatory pathway much faster. Our immediate aim isfor CUV9900 to be available for use in the clinic,” Dr Wright said"
CUV9900 was first announced in Aug 2010 - over 8 years ago. Clinical testing was expected to being in Q1 2011! No progress in that time.
A lesson in Clinuvel for the beginners.
Ann: CLINUVEL expands Singapore laboratory facilities, page-2
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.41 |
Change
1.510(10.9%) |
Mkt cap ! $766.6M | |||
| Open | High | Low | Value | Volume |
| $14.14 | $15.64 | $14.14 | $4.103M | 269.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14 | $15.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.42 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |